AKT1 and brain ischemia: Regarding the effects of TXL on Akt during I/R, Yu et al. previously reported that oral administration of TXL (three times a day for 3 days) alleviated cerebral ischemia and reperfusion injury in rats, through Akt activation (Yu et al., 2016).